Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

Affiliations

• ¹ Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
• ² Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
• ³ The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
• ⁴ Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA.
• ⁵ Departments of Neurology and Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.
• ⁶ Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
• ⁷ Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
• ⁸ Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, USA.
• ⁹ Department of Radiation Oncology, The Ohio State University College of Medicine, Columbus, OH, USA.
• ¹⁰ American Brain Tumor Association, Chicago, IL, USA.
• ¹¹ Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
• ¹² Bristol Myers Squibb, Princeton, NJ, USA.
• ¹³ Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.
• ¹⁴ Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA. diana.brixner@utah.edu.